Men at a high genetic risk adhering to a healthy lifestyle had a reduced risk of lethal prostate cancer compared with men at a high genetic risk not adhering to a healthy lifestyle. The genetic risk of prostate cancer may be modifiable.
Ruchika Talwar speaks with Chana Weinstock about the recent chemotherapy shortage affecting genitourinary cancers, notably muscle-invasive bladder cancer. Dr. Weinstock explains the complexity behind drug…
Robot-Assisted PSMA-Radioguided Surgery, Prostate Cancer, radical prostatectomy, Confocal microscopy, PSMA PET/CT, 68Ga-PSMA-11, robot-assisted radical prostatectomy (RARP), pelvic lymph node dissection (PLND), AURA 10 specimen PET/CT…
Alicia Morgans and Cheryl Lee discuss the need for equitable representation in clinical trials. Dr. Lee emphasizes the underrepresentation of minorities, low-income individuals, and those…
Zach Klaassen and Hanan Goldberg discuss the evolving landscape of nonmetastatic castration-resistant prostate cancer (nmCRPC), highlighting the impact of PSMA PET scans on diminishing this…
V-domain Immunoglobulin Suppressor of T cell Activation (VISTA), VISTA as a New Immunotherapy Target, tumor-infiltrating myeloid-derived suppressor cells, VISTA expression in the human tumor microenvironment,…
Michael Williams and Mark Fleming discuss their collaborative approach in managing patients with metastatic prostate cancer. Drs. Williams and Fleming emphasize the importance of multidisciplinary…
Ashish Kamat and Professor Sumanta (Monty) Pal discuss the microbiome’s influence on genitourinary cancers and immunotherapy. Highlighting foundational research, Dr. Pal explains how the gut…
Robot-Assisted Radical Cystectomy, patients with bladder cancer who underwent RARC versus open RC, bladder cancer, muscle-invasive bladder cancer, neoadjuvant chemotherapy, venous thromboembolic events.
Zach Klaassen is joined by Chandler Park and Ryan Malone to explore the collaborative approach between GU medical oncology and urology in managing metastatic hormone-sensitive…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan…
